- Home
- EBON vs DARE Comparison
EBON vs DARE Comparison
Compare EBON & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBON
- DARE
- Stock Information
- Founded
- EBON 2010
- DARE 2015
- Country
- EBON China
- DARE United States
- Employees
- EBON N/A
- DARE N/A
- Industry
- EBON Semiconductors
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- EBON Technology
- DARE Health Care
- Exchange
- EBON Nasdaq
- DARE Nasdaq
- Market Cap
- EBON 25.3M
- DARE 26.3M
- IPO Year
- EBON 2020
- DARE N/A
- Fundamental
- Price
- EBON $3.36
- DARE $2.44
- Analyst Decision
- EBON
- DARE Strong Buy
- Analyst Count
- EBON 0
- DARE 3
- Target Price
- EBON N/A
- DARE $12.50
- AVG Volume (30 Days)
- EBON 9.1K
- DARE 38.9K
- Earning Date
- EBON 08-22-2025
- DARE 08-11-2025
- Dividend Yield
- EBON N/A
- DARE N/A
- EPS Growth
- EBON N/A
- DARE N/A
- EPS
- EBON N/A
- DARE N/A
- Revenue
- EBON $5,868,771.00
- DARE $25,909.00
- Revenue This Year
- EBON N/A
- DARE $99,756.91
- Revenue Next Year
- EBON N/A
- DARE $119.77
- P/E Ratio
- EBON N/A
- DARE N/A
- Revenue Growth
- EBON 20.88
- DARE N/A
- 52 Week Low
- EBON $3.00
- DARE $2.35
- 52 Week High
- EBON $10.94
- DARE $4.60
- Technical
- Relative Strength Index (RSI)
- EBON 41.92
- DARE 35.15
- Support Level
- EBON $3.28
- DARE $2.37
- Resistance Level
- EBON $3.49
- DARE $2.54
- Average True Range (ATR)
- EBON 0.23
- DARE 0.11
- MACD
- EBON -0.00
- DARE -0.02
- Stochastic Oscillator
- EBON 29.57
- DARE 17.50
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.